MHN2 Stock Overview
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Reliq Health Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.13 |
52 Week High | CA$0.46 |
52 Week Low | CA$0.13 |
Beta | 1.64 |
1 Month Change | 0% |
3 Month Change | 0.30% |
1 Year Change | -61.63% |
3 Year Change | -66.08% |
5 Year Change | -10.48% |
Change since IPO | -96.24% |
Recent News & Updates
Recent updates
Shareholder Returns
MHN2 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | 0% | -0.9% | -0.8% |
1Y | -61.6% | -22.9% | 1.0% |
Return vs Industry: MHN2 underperformed the German Healthcare Services industry which returned -21.8% over the past year.
Return vs Market: MHN2 underperformed the German Market which returned 1.1% over the past year.
Price Volatility
MHN2 volatility | |
---|---|
MHN2 Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 4.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 9.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MHN2 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MHN2's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | n/a | Chris Shields | www.reliqhealth.com |
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016.
Reliq Health Technologies Inc. Fundamentals Summary
MHN2 fundamental statistics | |
---|---|
Market cap | €32.31m |
Earnings (TTM) | -€312.41k |
Revenue (TTM) | €9.98m |
3.2x
P/S Ratio-103.4x
P/E RatioIs MHN2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MHN2 income statement (TTM) | |
---|---|
Revenue | CA$14.62m |
Cost of Revenue | CA$5.76m |
Gross Profit | CA$8.86m |
Other Expenses | CA$9.32m |
Earnings | -CA$457.61k |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0021 |
Gross Margin | 60.61% |
Net Profit Margin | -3.13% |
Debt/Equity Ratio | 0.3% |
How did MHN2 perform over the long term?
See historical performance and comparison